List/Grid Tag Archives: ASCO 2011
ASCO 2011 ~ SIOPEN trial reveals better survival for BuMel for transplant regimen for neuroblastoma
Dr Ruth Ladenstein presents data in Plenary Session on randomized trial comparing BuMel vs CEM for transplant after Rapid COJEC induction
Considering that neuroblastoma accounts for 7% of pediatric cancers, and pediatric cancers comprises only 1% of adult cancers (that is .07% of all cancers, and high-risk NB makes up only half that number), it is really quite remarkable when highlighted presentations ...
ASCO 2011 ~ presentations of interest on neuroblastoma
ASCO meeting to convene this week
June 3 – 7 I will be in Chicago with 30,000 oncologists and oncology-related professionals (and 350 patient advocates) for the American Society of Clinical Oncology (ASCO) annual meeting, easily the largest oncology meeting in the world. Over 4000 abstracts have been accepted and many different types of sessions are presented including Education, Special, Plenary, Oral ...
